Cambridge Investment Research Advisors
CLS icon

Cambridge Investment Research Advisors’s Celestica CLS Stock Holding History

Cambridge Investment Research Advisors’s Portfolio CLS Stock Details CLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.5M Buy
28,848
+1,495
+5% +$561K 0.02% 649
2026
Q1 		$7.7M Sell
27,353
-1,708
-6% -$496K 0.02% 730
2025
Q4 		$8.59M Sell
29,061
-5,269
-15% -$1.59M 0.02% 645
2025
Q3 		$8.46M Buy
34,330
+8,410
+32% +$1.7M 0.02% 640
2025
Q2 		$4.04M Buy
25,920
+5,363
+26% +$570K 0.01% 965
2025
Q1 		$1.62M Buy
20,557
+964
+5% +$102K 0.01% 1484
2024
Q4 		$1.81M Sell
19,593
-7,632
-28% -$597K 0.01% 1429
2024
Q3 		$1.39M Buy
27,225
+2,139
+9% +$111K ﹤0.01% 1611
2024
Q2 		$1.44M Sell
25,086
-24,287
-49% -$1.23M 0.01% 1520
2024
Q1 		$2.22M Buy
+49,373
New +$1.87M 0.01% 1194

Other funds holding CLS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
CIBC World Market
CIBC World Market Toronto, Ontario, Canada $62.3B AUM 44.64% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $40.1B AUM 376.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Cambridge Investment Research Advisors's CLS Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its Celestica (CLS) stake by 5.5% in Q2 2026, buying an estimated $561K and bringing the position to 28,848 shares worth $10.5M. The position accounts for 0.02% of the portfolio, ranked #649.

Cambridge Investment Research Advisors first reported a position in CLS in Q1 2024 and has held it in 10 quarters since. 879 funds tracked by Wall St. Rank hold CLS as of Q2 2026.

  • Cambridge Investment Research Advisors held 28,848 shares of Celestica worth $10.5M as of Q2 2026.
  • Cambridge Investment Research Advisors bought 1,495 Celestica shares in Q2 2026, an estimated $561K.
  • Celestica made up 0.02% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #649 holding.
  • Cambridge Investment Research Advisors first reported a position in Celestica in Q1 2024 and has held it in 10 quarters since.
  • 879 funds tracked by Wall St. Rank held Celestica as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.